Synapse - Howard Scher

Results (200)

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Journal Article

Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
Nature Medicine (2022)

Fulltext@MSK | Save

Evaluation of an integrated spectroscopy and classification platform for point-of-care core needle biopsy assessment: Performance characteristics from ex vivo renal mass biopsies

Journal Article

Keshavamurthy, K. N.; Dylov, D. V.; Yazdanfar, S.; Patel, D.; Silk, T.; Silk, M.; Jacques, F.; Petre, E. N.; Gonen, M.; Rekhtman, N.; more...
Journal of Vascular and Interventional Radiology (2022)

Fulltext@MSK | Save

The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer

Journal Article

Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation

Journal Article

Mathur, D.; Taylor, B. P.; Chatila, W. K.; Scher, H. I.; Schultz, N.; Razavi, P.; Xavier, J. B.
Molecular Cancer Therapeutics (2022)

Fulltext@MSK | Save

Automated bone scan index to optimize prostate cancer working group radiographic progression criteria for men with metastatic castration-resistant prostate cancer

Journal Article

Anand, A.; Heller, G.; Fox, J.; Danila, D. C.; Bjartell, A.; Edenbrandt, L.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Clinical Genitourinary Cancer (2022)

Fulltext@MSK | Save

Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients

Journal Article

Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
Clinical Genitourinary Cancer (2022)

Fulltext@MSK | Save

Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors

Journal Article

Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study

Journal Article

Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
Journal of Nuclear Medicine (2021)

Fulltext@MSK | Save

Randomized phase 2 trial of abiraterone acetate plus prednisone, degarelix, or the combination in men with biochemically recurrent prostate cancer after radical prostatectomy

Journal Article

Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Shevrin, D. H.; Stein, M. N.; Vaishampayan, U. N.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; Tagawa, S. T.; more...
European Urology Open Science (2021)

Fulltext@MSK | Save

Phase 3 randomized controlled trial of androgen deprivation therapy with or without docetaxel in high-risk biochemically recurrent prostate cancer after surgery (TAX3503)

Journal Article

Morris, M. J.; Mota, J. M.; Lacuna, K.; Hilden, P.; Gleave, M.; Carducci, M. A.; Saad, F.; Cohn, E. D.; Filipenko, J.; Heller, G.; more...
European Urology Oncology (2021)

Fulltext@MSK | Save